Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
The podcast can be downloaded here and is embedded below. Subscribe to the podcast via Apple Podcast, Google Play, Spotify or the RSS feed. Updates on the podcast on Twitter at @Lawbytespod.
Credits:
CTV News, Canada’s Chief Public Health Officer Says a Coronavirus Vaccine is ‘Probably’ a Year Away
Facial recognition technologies have attracted mounting attention in recent weeks led by a New York Times report on Clearview AI, soon followed by revelations...
The recent dust-up between Twitter and the CBC over a “government funded media” label sparked fiery rhetoric from both sides. Opponents of the CBC...
Copyright term extension has emerged as a major policy issue in Canada in recent months. Canada’s general copyright term is life of the author...